Jianpu Technology (JT) versus National Research (NRCIA) Financial Contrast

Jianpu Technology (NYSE: JT) and National Research (NASDAQ:NRCIA) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Profitability

How to Become a New Pot Stock Millionaire

This table compares Jianpu Technology and National Research’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Jianpu Technology N/A N/A N/A
National Research 19.52% 27.45% 19.09%

Insider & Institutional Ownership

33.7% of National Research shares are owned by institutional investors. 5.7% of National Research shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Jianpu Technology and National Research, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jianpu Technology 0 2 1 0 2.33
National Research 0 0 0 0 N/A

Jianpu Technology presently has a consensus target price of $8.83, suggesting a potential upside of 46.25%. Given Jianpu Technology’s higher probable upside, equities analysts clearly believe Jianpu Technology is more favorable than National Research.

Earnings and Valuation

This table compares Jianpu Technology and National Research’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Jianpu Technology $222.21 million 4.50 -$20.96 million N/A N/A
National Research $117.56 million 6.03 $22.94 million $0.52 55.67

National Research has lower revenue, but higher earnings than Jianpu Technology.

Dividends

National Research pays an annual dividend of $0.40 per share and has a dividend yield of 1.4%. Jianpu Technology does not pay a dividend. National Research pays out 76.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

National Research beats Jianpu Technology on 8 of the 12 factors compared between the two stocks.

About Jianpu Technology

Jianpu Technology Inc. provides an open platform for discovery and recommendation of financial products in China. The Company, through its technology, provides users with personalized search results and recommendations that are tailored to each user’s particular financial needs and credit profile. Financial service providers offer a wide variety of financial products on our platform, including consumer and other loans, credit cards, and wealth management products. The Company also provides a wide range of services and solutions to financial service providers on its platform, including sales and marketing solutions, big data risk management solutions and integrated solutions through Gold Cloud. It also provides professional content on financial products, the financial industry and personal finances in many forms, including short videos, audio, online articles and offline booklets and handouts.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect. The Company’s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions and physician engagement. NRC Health partners with clients across the range of healthcare services. The Company’s clients range from integrated health systems and post-acute providers, such as home health, long-term care and hospice, to payer organizations. NRC Health’s portfolio of solutions is designed to help healthcare companies.

Receive News & Ratings for Jianpu Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jianpu Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Jewett-Cameron Trading Co  Stake Held by Fort Nelson Partners, LP
Jewett-Cameron Trading Co Stake Held by Fort Nelson Partners, LP
Greenhill & Co.  and GAMCO Investors  Critical Review
Greenhill & Co. and GAMCO Investors Critical Review
STRAKS Tops 1-Day Volume of $24,012.00
STRAKS Tops 1-Day Volume of $24,012.00
KlondikeCoin  Achieves Market Capitalization of $0.00
KlondikeCoin Achieves Market Capitalization of $0.00
Roku  and Its Competitors Head to Head Survey
Roku and Its Competitors Head to Head Survey
Pentair  vs. Metso  Financial Analysis
Pentair vs. Metso Financial Analysis


© 2006-2018 Ticker Report. Google+.